Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
SMS LIFESCIENCES INDIA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SMS LIFESCIENCES INDIA Mar-23 |
TEVA PHARMA Dec-13 |
SMS LIFESCIENCES INDIA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 948 | 3,480 | - | |
Low | Rs | 501 | 3,023 | - | |
Sales per share (Unadj.) | Rs | 903.8 | 1,997.4 | - | |
Earnings per share (Unadj.) | Rs | 37.7 | 124.8 | - | |
Cash flow per share (Unadj.) | Rs | 73.4 | 286.2 | - | |
Dividends per share (Unadj.) | Rs | 1.50 | 109.23 | - | |
Avg Dividend yield | % | 0.2 | 3.4 | 6.2% | |
Book value per share (Unadj.) | Rs | 558.3 | 2,218.7 | - | |
Shares outstanding (eoy) | m | 3.02 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.8 | 1.6 | 49.3% | |
Avg P/E ratio | x | 19.2 | 26.1 | 73.9% | |
P/CF ratio (eoy) | x | 9.9 | 11.4 | 87.0% | |
Price / Book Value ratio | x | 1.3 | 1.5 | 88.6% | |
Dividend payout | % | 4.0 | 87.5 | 4.6% | |
Avg Mkt Cap | Rs m | 2,190 | 2,757,543 | 0.1% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 434 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,685.6 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,354.2 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 2,730 | 1,693,781 | 0.2% | |
Other income | Rs m | 31 | 0 | - | |
Total revenues | Rs m | 2,760 | 1,693,781 | 0.2% | |
Gross profit | Rs m | 312 | 463,843 | 0.1% | |
Depreciation | Rs m | 108 | 136,910 | 0.1% | |
Interest | Rs m | 69 | 33,269 | 0.2% | |
Profit before tax | Rs m | 166 | 293,664 | 0.1% | |
Minority Interest | Rs m | 0 | 1,334 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,775 | -0.0% | |
Tax | Rs m | 52 | -3,585 | -1.5% | |
Profit after tax | Rs m | 114 | 105,809 | 0.1% | |
Gross profit margin | % | 11.4 | 27.4 | 41.7% | |
Effective tax rate | % | 31.4 | -1.2 | -2,574.5% | |
Net profit margin | % | 4.2 | 6.2 | 66.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,626 | 1,143,974 | 0.1% | |
Current liabilities | Rs m | 1,371 | 997,642 | 0.1% | |
Net working cap to sales | % | 9.4 | 8.6 | 108.4% | |
Current ratio | x | 1.2 | 1.1 | 103.5% | |
Inventory Days | Days | 9 | 91 | 9.7% | |
Debtors Days | Days | 616 | 96 | 642.2% | |
Net fixed assets | Rs m | 2,358 | 553,226 | 0.4% | |
Share capital | Rs m | 30 | 4,169 | 0.7% | |
Net worth | Rs m | 1,686 | 1,881,470 | 0.1% | |
Long term debt | Rs m | 549 | 866,068 | 0.1% | |
Total assets | Rs m | 3,984 | 3,870,833 | 0.1% | |
Interest coverage | x | 3.4 | 9.8 | 34.8% | |
Debt to equity ratio | x | 0.3 | 0.5 | 70.8% | |
Sales to assets ratio | x | 0.7 | 0.4 | 156.6% | |
Return on assets | % | 4.6 | 3.6 | 127.5% | |
Return on equity | % | 6.7 | 5.6 | 120.0% | |
Return on capital | % | 10.5 | 4.9 | 212.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 147 | 269,901 | 0.1% | |
From Investments | Rs m | -313 | -95,637 | 0.3% | |
From Financial Activity | Rs m | 169 | -323,765 | -0.1% | |
Net Cashflow | Rs m | 3 | -149,500 | -0.0% |
Compare SMS LIFESCIENCES INDIA With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare SMS LIFESCIENCES INDIA With: ORCHID PHARMA JFL LIFE SCIENCES LTD. DISHMAN PHARMA LYKA LABS SAKAR HEALTHCARE
Asian markets traded higher on Tuesday following overnight gain on Wall Street.